West-Ward Pharmaceuticals International Limited vs. Novartis AG
Explore the PTAB proceeding IPR2017-01078 filed by West-Ward Pharmaceuticals International Limited on 2017-03-13. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-01078
Filing Date
2017-03-13
Accorded Filing Date
2017-03-13
Institution Decision Date
โ
Last Modified Date
2022-06-24
Proceeding Type
IPR
Termination Date
2017-09-25
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
West-Ward Pharmaceuticals International Limited
Represented By
Keith ZullowPatent Owner / Respondent
Novartis AG
Represented By
Nicholas KallasPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 39030 | Jean Silveri | +1 617-871-5134 |
| 40232 | Timothy Witkowski | +1 617-301-1869 |
| 43228 | Peter Waibel | +1 862-778-7838 |
| 46473 | Emily Wu | +1 858-812-1539 |
| 46593 | Laurie Lawrence | +1 617-871-8584 |
| 48631 | Carol Fang | +1 650-467-2901 |
| 51681 | Mark Flanigan | +1 817-615-5080 |
| 53504 | Daniel Raymond | +1 858-812-1617 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,006,224 Asserted | Asserted Patent | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0523658 A | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0601082 | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0602747 | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0607942 | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0609272 | United Kingdom Counterpart | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 0609912 A | United Kingdom Counterpart | View Official Patent → |
| ๐ช๐บ European Patent Office (UPC States) | EP 6,120,660 | European Counterpart (EP) | View Official Patent → |
| ๐ฌ๐ง United Kingdom | GB 06120660 | United Kingdom Counterpart | View Official Patent → |
| ๐ PCT International (WIPO) | WO 2007057457 A2 | PCT World Application | View Official Patent → |
| ๐บ๐ธ United States | US 2015014829 | US Continuation / Sibling | View Official Patent → |
Argentum Pharmaceuticals LLC et al. v. Novartis AG
Par Pharmaceutical, Inc. et al. v. Novartis AG
Roxane Laboratories, Inc. et al. v. Novartis AG